Project Number EUJPND-ParkUK-Cooper-2108 Agency/Funding Organization Parkinson's UK Funding Year 2016 View Full Project Details for Modifing the exosomal release of alpha synuclein as a potential target to prevent disease progression in Parkinson's Research Categorization Primary Disease / Condition Lewy Body Dementias CADRO Category A. Molecular Pathogenesis and Physiology of Alzheimer's Disease and Alzheimer's Disease-related Dementias (AD/ADRDs) 5. Other Proteinopathies a. Alpha-Synuclein Researcher and Organization Principal Investigator Cooper, Jonathan Principal Investigator First Name Jonathan Principal Investigator Last Name Cooper Awardee Organization University College London Contact PI Country United Kingdom Project Detail FY Overall Cost $110,111 Funding Organization Agency/Funding Organization Parkinson's UK Funding Organization Country United Kingdom Special Initiative EU Joint Programme - Neurodegenerative Disease Research - Research Mapping (2016)
